When this happens, some people don't have enough lactase to break down the lactose in their food
Using it after a gastric bypass is considered off-label, meaning your doctor is prescribing it based on their clinical judgement and the available research, rather than a specific approval for this purpose
It was the first treatment FDA Market Cleared for overall body circumference reduction
And you are not alone
In just 18 months, weight loss has become one of Hims & Hers' largest specialties, CEO Andrew Dudum told investors during its Q1 earnings call in May
Approved for an obesity indication in November 2023, Zepbound could see between $2.2 billion in sales, according to Morgan Stanley, or hit $2.7 billion for the year, according to Bank of America forecasts